Geoffrey A. Swire
Director de Operaciones en ALLENA PHARMACEUTICALS, INC. .
Cargos activos de Geoffrey A. Swire
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ALLENA PHARMACEUTICALS, INC. | Director de Operaciones | 10/11/2020 | - |
| Corporate Officer/Principal | 01/01/2018 | - |
Historial de carrera de Geoffrey A. Swire
Antiguos cargos conocidos de Geoffrey A. Swire.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
| RADIUS HEALTH, INC. | Corporate Officer/Principal | - | - |
Formación de Geoffrey A. Swire.
| Dartmouth College | Undergraduate Degree |
| Harvard University | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Chief Operating Officer | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Geoffrey A. Swire
- Experiencia